Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Mental Disorders Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Mental Disorders Drugsmarket, defines the market attractiveness level of Mental Disorders Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Mental Disorders Drugs industry, describes the types of Mental Disorders Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Mental Disorders Drugs market and the development prospects and opportunities of Mental Disorders Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Mental Disorders Drugs market in Chapter 13.
By Player:
Eli Lilly
Johnson & Johnson
GlaxoSmithKline
AstraZeneca
Pfizer
Abbott Laboratories
Bristol-Myers Squibb
By Type:
Drugs for Schizophrenia
Antidepressants
Antipsychotics
Anxiolytics
Drugs for the Treatment of Substance and Alcohol Addiction
Drugs for Childhood and Adolescent Mental Illness
Drugs to Treat Cognitive Disorders
Sleep Disorders
Others
By End-User:
Children
Adolescents
Adults
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Mental Disorders Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Mental Disorders Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Mental Disorders Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Mental Disorders Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Mental Disorders Drugs Market Analysis and Outlook to 2022
-
7.1 Global Mental Disorders Drugs Consumption (2017-2022)
-
7.2 United States Mental Disorders Drugs Consumption (2017-2022)
-
7.3 Europe Mental Disorders Drugs Consumption (2017-2022)
-
7.4 China Mental Disorders Drugs Consumption (2017-2022)
-
7.5 Japan Mental Disorders Drugs Consumption (2017-2022)
-
7.6 India Mental Disorders Drugs Consumption (2017-2022)
-
7.7 South Korea Mental Disorders Drugs Consumption (2017-2022)
8 Region and Country-wise Mental Disorders Drugs Market Analysis and Outlook to 2028
-
8.1 Global Mental Disorders Drugs Consumption Forecast (2022-2028)
-
8.2 United States Mental Disorders Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Mental Disorders Drugs Consumption Forecast (2022-2028)
-
8.4 China Mental Disorders Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Mental Disorders Drugs Consumption Forecast (2022-2028)
-
8.6 India Mental Disorders Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Mental Disorders Drugs Consumption Forecast (2022-2028)
9 Global Mental Disorders Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Mental Disorders Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Drugs for Schizophrenia Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antidepressants Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Antipsychotics Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Anxiolytics Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Drugs for the Treatment of Substance and Alcohol Addiction Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Drugs for Childhood and Adolescent Mental Illness Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Drugs to Treat Cognitive Disorders Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Sleep Disorders Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Mental Disorders Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Children Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adolescents Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Adults Consumption and Growth Rate (2017-2022)
10 Global Mental Disorders Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Mental Disorders Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Drugs for Schizophrenia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Antipsychotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Anxiolytics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Drugs for the Treatment of Substance and Alcohol Addiction Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Drugs for Childhood and Adolescent Mental Illness Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Drugs to Treat Cognitive Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Sleep Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Mental Disorders Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Children Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Adolescents Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Adults Consumption Forecast and Growth Rate (2022-2028)
11 Global Mental Disorders Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Mental Disorders Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Mental Disorders Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Mental Disorders Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Mental Disorders Drugs Market Competitive Analysis
-
14.1 Eli Lilly
-
14.1.1 Eli Lilly Company Details
-
14.1.2 Eli Lilly Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly Mental Disorders Drugs Product and Service
-
14.2 Johnson & Johnson
-
14.2.1 Johnson & Johnson Company Details
-
14.2.2 Johnson & Johnson Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Johnson & Johnson Mental Disorders Drugs Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Mental Disorders Drugs Product and Service
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Details
-
14.4.2 AstraZeneca Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca Mental Disorders Drugs Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Mental Disorders Drugs Product and Service
-
14.6 Abbott Laboratories
-
14.6.1 Abbott Laboratories Company Details
-
14.6.2 Abbott Laboratories Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Abbott Laboratories Mental Disorders Drugs Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Mental Disorders Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Mental Disorders Drugs
-
Figure Mental Disorders Drugs Picture
-
Table Global Mental Disorders Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Mental Disorders Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Mental Disorders Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Mental Disorders Drugs Consumption by Country (2017-2022)
-
Figure United States Mental Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Mental Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Mental Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Mental Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Mental Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Mental Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Mental Disorders Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Mental Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Mental Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Mental Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Mental Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Mental Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Mental Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs for Schizophrenia Consumption and Growth Rate (2017-2022)
-
Figure Global Antidepressants Consumption and Growth Rate (2017-2022)
-
Figure Global Antipsychotics Consumption and Growth Rate (2017-2022)
-
Figure Global Anxiolytics Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs for the Treatment of Substance and Alcohol Addiction Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs for Childhood and Adolescent Mental Illness Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs to Treat Cognitive Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Sleep Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Children Consumption and Growth Rate (2017-2022)
-
Figure Global Adolescents Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs for Schizophrenia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antipsychotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anxiolytics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs for the Treatment of Substance and Alcohol Addiction Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs for Childhood and Adolescent Mental Illness Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs to Treat Cognitive Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sleep Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Children Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adolescents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Mental Disorders Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Mental Disorders Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Mental Disorders Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Mental Disorders Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Mental Disorders Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Mental Disorders Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Mental Disorders Drugs Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Mental Disorders Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Mental Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Mental Disorders Drugs Product and Service
-
